BAYER PHARMA AKTIENGESELLSCHAFT

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 170100
 
  
 
C07D HETEROCYCLIC COMPOUNDS 16344
 
  
 
C07K PEPTIDES 12124
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 1159
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 8130
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 788
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 7147
 
  
 
C07J STEROIDS514
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 3237

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0065,981 HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTORMar 21, 16Mar 08, 18[A61K, C07D]
2018/0042,929 USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINESMar 07, 16Feb 15, 18[A61K, C12Q]
2018/0042,931 N-PHENYL-(MORPHOLIN-4-YL OR PIPERAZINYL)ACETAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE WNT SIGNALLING PATHWAYSFeb 16, 16Feb 15, 18[A61K, C07D]
2018/0044,306 1,3,4-THIADIAZOL-2-YL-BENZAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAYFeb 16, 16Feb 15, 18[A61K, C07D]
2018/0028,507 3-CARBAMOYLPHENYL-4-CARBOXAMIDE AND ISOPHTALAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAYFeb 16, 16Feb 01, 18[A61K, C07D, C07C]
2018/0022,750 6-HYDROXYBENZOFURANYL- AND 6-ALKOXYBENZOFURANYL-SUBSTITUTED IMIDAZOPYRIDAZINESDec 21, 15Jan 25, 18[A61K, C07D]
2018/0022,780 STABILIZATION ADRENOMEDULLIN DERIVATIVES AND USE THEREOFSep 24, 15Jan 25, 18[A61K, C07K]
2018/0016,272 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVESJan 25, 16Jan 18, 18[A61K, C07D]
2017/0368,069 USE OF 4-(4-FLUORO-2-METHOXYPHENYL)-N--1,3,5-TRIAZIN-2-AMINE FOR TREATING LEUKEMIASJan 08, 16Dec 28, 17[A61K, C12Q]
2017/0342,034 NOVEL ARYL-CYANOGUANIDINE COMPOUNDSDec 08, 15Nov 30, 17[C07D]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9918969 Substituted oxopyridine derivatives and use thereof as factor XIa/plasmaOct 24, 16Mar 20, 18[A61K, C07D]
9902716 Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone groupOct 13, 15Feb 27, 18[A61K, C07D]
9890147 2,3-benzodiazepinesAug 13, 13Feb 13, 18[A61K, C07D]
9884063 Amido-substituted azole compoundsApr 01, 15Feb 06, 18[A61K, C07D]
9884849 Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine groupOct 14, 15Feb 06, 18[A61K, C07D]
9877954 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupApr 03, 17Jan 30, 18[A61K]
9862171 Laminate changing deviceOct 09, 15Jan 09, 18[A61F, B32B, A61M]
9856242 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone groupMar 12, 15Jan 02, 18[A61K, C07D]
9827198 Pharmaceutical dosage forms comprising sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olateOct 13, 14Nov 28, 17[A61K]
9822102 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersSep 04, 16Nov 21, 17[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0305,912 PROCESS FOR THE PREPARATION OF 3-PHENYL/HETEROARYL-6-PHENOXY-8-ALKYLAMINO-IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVESAbandonedAug 28, 15Oct 26, 17[C07D, C07B]
2017/0275,267 SUBSTITUTED CYCLOALKENOPYRAZOLES AS BUB1 INHIBITORS FOR THE TREATMENT OF CANCERAbandonedMar 08, 17Sep 28, 17[A61K, C07F, C07D]
2017/0275,268 HETEROARYL SUBSTITUTED INDAZOLESAbandonedMar 10, 17Sep 28, 17[A61K, C07D]
2017/0233,345 SUBSTITUTED QUINOLINE-4-CARBOXAMIDES AND USE THEREOFAbandonedAug 11, 15Aug 17, 17[A61K, C07D]
2017/0233,413 SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOFAbandonedAug 25, 15Aug 17, 17[A61K, C07D]
2017/0226,081 GLUCOSE TRANSPORT INHIBITORSAbandonedJul 22, 15Aug 10, 17[A61K, C07D]
2017/0210,738 GLUCOSE TRANSPORT INHIBITORSAbandonedJul 22, 15Jul 27, 17[A61K, C07D]
2017/0197,979 BENZOTHIADIAZOLAMINESAbandonedMay 26, 15Jul 13, 17[A61K, C07D]
2017/0145,058 METHOD FOR TARGETED CONJUGATION OF PEPTIDES AND PROTEINS BY PAIRED C2 BRIDGING OF CYSTEINE AMINO ACIDSAbandonedMay 05, 15May 25, 17[C07K]
2017/0119,776 CHIRAL 2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND USE THEREOFAbandonedMar 31, 15May 04, 17[A61K, C07D]
2017/0114,049 2,5-DISUBSTITUTED CYCLOPENTANE CARBOXYLIC ACIDS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASESAbandonedMar 31, 15Apr 27, 17[A61K, C07D]
2017/0114,070 INHIBITORS OF THE WNT SIGNALLING PATHWAYSAbandonedMar 18, 15Apr 27, 17[A61K, C07D, C07C]
2017/0107,229 SUBSTITUTED TETRAHYDROPYRIDOTHIENOPYRIMIDINESAbandonedMay 22, 15Apr 20, 17[A61K, C07D]
2017/0101,407 6-CHLORINE-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE CARBOXAMIDES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE STIMULATORSAbandonedApr 29, 15Apr 13, 17[A61K, C07D]
2017/0057,954 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USEAbandonedMar 19, 15Mar 02, 17[A61K, C07D]
2017/0057,958 ENANTIOMERS OF THE N-(2-AMINO-5-FLUORO-2-METHYLPENTYL)-8-[(2,6-DIFLUOROBENZYL)OXY]-2-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE, AS WELL AS OF THE DI- AND TRIFLUORO DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISEASESAbandonedApr 29, 15Mar 02, 17[A61K, C07D]
2017/0050,961 IMIDAZO[1,2-A]PYRIDINES AS SOLUBLE GUANYLATE CYCLASE STIMULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASESAbandonedApr 29, 15Feb 23, 17[A61K, C07F, C07D]
2017/0050,962 IMIDAZO[1,2-A]PYRIDINES AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE FOR TREATING CARDIOVASCULAR DISEASESAbandonedApr 29, 15Feb 23, 17[A61K, C07D]
2017/0022,171 2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACIDS AND THEIR USEAbandonedMar 31, 15Jan 26, 17[A61K, C07D]
2017/0008,876 Metal Chelate Compounds for Binding to the Platelet Specific Glycoprotein IIb/IIIaAbandonedFeb 06, 15Jan 12, 17[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.